UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TECH — BIO-TECHNE Corp
CIK 861177
NEW YORK, NY
Position in TECH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$22,961,628
-$1,896,119 QoQ
Shares Held
439,373
+3.9% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. TECH ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in TECH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,961,628 | 439,373 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $24,857,747 | 422,679 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $30,926,492 | 555,932 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,093,194 | 818,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,365,886 | 944,327 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $66,607,647 | 924,721 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $60,294,709 | 754,344 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $52,595,893 | 734,067 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $38,219,724 | 542,971 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $42,984,595 | 557,084 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,896,196 | 556,724 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $37,533,632 | 459,802 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $34,112,704 | 459,802 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $38,126,368 | 460,019 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,325,815 | 117,265 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,666,076 | 134,619 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,546,022 | 143,599 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,180,615 | 140,570 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,697,066 | 137,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,400,773 | 127,933 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,692,926 | 80,569 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,349,251 | 79,978 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $4,259,342 | 68,774 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,373,326 | 66,245 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,525,830 | 53,282 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||